| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,472 | 29,337 | 29,051 | 30,277 | | Cost of Revenue | 5,995 | 6,809 | 7,557 | 8,973 | | | Gross Profit |
-
| 22,528 | 21,494 | 21,304 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 19,004 | 18,867 | 19,817 | 135,808 | | Non Recurring | 18,741 | 52 | 59 | (109,366) | | Others | 9,716 | 12,516 | 14,396 | 41,183 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (8,907) | (12,778) | (46,321) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (26,984) | (8,907) | (12,778) | (46,321) | | Interest Expense | 1,409 | 1,620 | 1,757 | 2,108 | | Income Before Tax | (28,393) | (10,527) | (14,535) | (48,429) | | Income Tax Expense |
-
|
-
|
-
| 9,267 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (28,393) | (10,527) | (14,535) | (57,696) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (28,393) | (10,527) | (14,535) | (57,696) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($28,393) | ($10,527) | ($14,535) | ($57,696) |
|
0.51% Nasdaq 
0.01 (2.27%) 
Income Statement
